Sökning: "papillary thyroid carcinoma"
Visar resultat 6 - 10 av 11 avhandlingar innehållade orden papillary thyroid carcinoma.
6. Diagnostic and prognostic markers in thyroid carcinoma with focus on TERT activation
Sammanfattning : Well-differentiated follicular cell-derived thyroid carcinomas are usually categorized into papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC), which represent the most common and second most common types of thyroid carcinoma, respectively. PTC patients generally have a good prognosis, although a subset of patients progress in their disease with poor clinical outcome. LÄS MER
7. Basic and translational studies of follicular thyroid neoplasia
Sammanfattning : Thyroid tumors occur frequently in the general population and although the majority represents benign follicular adenomas (FTA), thyroid cancer constitutes 1% of all malignancies worldwide. Among the differentiated cancers, three main types are recognized, including the papillary and follicular forms (PTC and FTC) that originate from the follicular thyrocytes, and the medullary carcinoma that arises from the C-cells. LÄS MER
8. Behind the scenes of thyroid tumors : underlying genetic mechanisms
Sammanfattning : Thyroid cancer is the most frequently observed malignancy involving endocrine tissues. This group of diseases is also the major cause of death related to neoplasia of the endocrine system. Tumors in the thyroid gland are common in the general population and the majority represents benign follicular adenoma (FTA). LÄS MER
9. In search of diagnostic and prognostic markers for thyroid cancer : a proteomics approach
Sammanfattning : Early diagnosis of cancer can influence the therapeutic strategy increasing the chances of cure or, at least, prolonged survival. It is equally important to be able to detect prognostic signs, i.e. tumor features that characterize its behavior. LÄS MER
10. Promoter mutations/methylation in thyroid and urothelial carcinomas : biological and clinical implications
Sammanfattning : Genetic and epigenetic aberrations are well established to drive cancer development and progression. However, the underlying mechanisms are incompletely understood, and the translational applications of aberrant alterations are limited in gene non-coding regions, such as the promoter locus. LÄS MER